These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17166859

  • 1. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections.
    Zoccali C, Maas R, Cutrupi S, Pizzini P, Finocchiaro P, Cambareri F, Panuccio V, Martorano C, Schulze F, Enia G, Tripepi G, Boger R.
    Nephrol Dial Transplant; 2007 Mar; 22(3):801-6. PubMed ID: 17166859
    [Abstract] [Full Text] [Related]

  • 2. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.
    Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R.
    Minerva Anestesiol; 2010 May; 76(5):325-33. PubMed ID: 20395894
    [Abstract] [Full Text] [Related]

  • 3. Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study.
    van der Zwan LP, Scheffer PG, Dekker JM, Stehouwer CD, Heine RJ, Teerlink T.
    Clin Sci (Lond); 2011 Jul; 121(2):71-8. PubMed ID: 21306304
    [Abstract] [Full Text] [Related]

  • 4. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
    Javadiyan S, Burdon KP, Whiting MJ, Abhary S, Straga T, Hewitt AW, Mills RA, Craig JE.
    Invest Ophthalmol Vis Sci; 2012 Apr 18; 53(4):1923-7. PubMed ID: 22395885
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
    Goonasekera CD, Rees DD, Woolard P, Frend A, Shah V, Dillon MJ.
    J Hypertens; 1997 Aug 18; 15(8):901-9. PubMed ID: 9280214
    [Abstract] [Full Text] [Related]

  • 6. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
    Wang Z, Tang WH, Cho L, Brennan DM, Hazen SL.
    Arterioscler Thromb Vasc Biol; 2009 Sep 18; 29(9):1383-91. PubMed ID: 19542023
    [Abstract] [Full Text] [Related]

  • 7. Plasma dimethylarginines during the acute inflammatory response.
    Blackwell S, O'Reilly DS, Reid D, Talwar D.
    Eur J Clin Invest; 2011 Jun 18; 41(6):635-41. PubMed ID: 21175611
    [Abstract] [Full Text] [Related]

  • 8. Acute Escherichia coli endotoxaemia decreases the plasma l-arginine/asymmetrical dimethylarginine ratio in humans.
    Mittermayer F, Namiranian K, Pleiner J, Schaller G, Wolzt M.
    Clin Sci (Lond); 2004 Jun 18; 106(6):577-81. PubMed ID: 14741043
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy.
    Kurz K, Teerlink T, Sarcletti M, Weiss G, Zangerle R, Fuchs D.
    Antivir Ther; 2012 Jun 18; 17(6):1021-7. PubMed ID: 22892398
    [Abstract] [Full Text] [Related]

  • 12. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure.
    MacAllister RJ, Rambausek MH, Vallance P, Williams D, Hoffmann KH, Ritz E.
    Nephrol Dial Transplant; 1996 Dec 18; 11(12):2449-52. PubMed ID: 9017621
    [Abstract] [Full Text] [Related]

  • 13. Subarachnoid haemorrhage induces an inflammatory response followed by a delayed persisting increase in asymmetric dimethylarginine.
    Rodling-Wahlström M, Olivecrona M, Koskinen LO, Naredi S, Hultin M.
    Scand J Clin Lab Invest; 2012 Oct 18; 72(6):484-9. PubMed ID: 22939167
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G.
    Kidney Int Suppl; 2001 Feb 18; 78():S14-8. PubMed ID: 11168976
    [Abstract] [Full Text] [Related]

  • 16. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
    Wang J, Sim AS, Wang XL, Salonikas C, Naidoo D, Wilcken DE.
    Atherosclerosis; 2006 Feb 18; 184(2):383-8. PubMed ID: 15939423
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dimethylarginine levels and nutritional status in hemodialysis patients.
    Cupisti A, Saba A, D'Alessandro C, Meola M, Panicucci E, Panichi V, Raffaelli A, Barsotti G.
    J Nephrol; 2009 Feb 18; 22(5):623-9. PubMed ID: 19809995
    [Abstract] [Full Text] [Related]

  • 19. Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes.
    Marcovecchio ML, Widmer B, Dunger DB, Dalton RN.
    Clin Sci (Lond); 2008 Dec 18; 115(12):361-9. PubMed ID: 18498242
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
    Notsu Y, Nabika T, Bokura H, Suyama Y, Kobayashi S, Yamaguchi S, Masuda J.
    Am J Hypertens; 2009 Mar 18; 22(3):257-62. PubMed ID: 19057516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.